BIOMOTION SCIENCES WARRANT (NASDAQ: SLXNW)

NASDAQ: SLXNW (Biomotion Sciences Warrant)

Kemas kini terakhir: 06 Sep, 12:06AM

0.00 (7.24%)

Tambah ke senarai pantauan

Julat 52 Minggu

0.033 (0%) — 0.033 (0%)

Arah Aliran Pasaran

AISkor Stockmoo

0.0

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
SLXNW	-	-	-	-
BNTX	23 B	-	-	1.08
IMCR	2 B	-	-	4.46
GPCR	1 B	-	-	1.76
ZBIO	798 M	-	-	3.21
SEPN	642 M	-	-	1.85

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Sektor	Healthcare
Industri	Biotechnology

Tiada data dalam julat masa ini.

Portfolio

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Tiada saham yang memenuhi kriteria anda

Jumlah Hutang/Ekuiti (D/E MRQ)	8.94%
Nisbah Semasa (MRQ)	0.640
Aliran Tunai Operasi (OCF TTM)	-8.40 M
Aliran Tunai Bebas Leveraj (LFCF TTM)	-2.41 M

Pulangan Atas Aset (ROA TTM)	-193.54%
Pulangan Atas Ekuiti (ROE TTM)	-116.66%